Proton MR spectroscopic imaging in Pelizaeus-Merzbacher disease

Francesca Pizzini, Ali S. Fatemi, Peter B. Barker, Lidia M. Nagae-Poetscher, Alena Horská, Andrew W. Zimmerman, Hugo W. Moser, Genila Bibat, Sakkubai Naidu

Research output: Contribution to journalArticle

Abstract

BACKGROUND AND PURPOSE: Pelizeaus-Merzbacher disease (PMD) is a clinically and molecularly heterogeneous disorder linked to deletion, mutations, or duplication of the proteolipid protein (PLP1) gene locus at Xq22. The current study was conducted to characterize the results of proton MR spectroscopic (MRS) imaging in PMD. METHODS: Three boys with PMD (one with the severe connatal form and two with a more mild clinical phenotype [spastic paraplegia type 2]). and three age-matched healthy control subjects (age range, 2-7 years) underwent MR and MRS imaging. All imaging was performed at 1.5 T. For MRS imaging, oblique-axial sections (thickness, 15 mm; intersection gap, 2.5 mm) were recorded parallel to the anterior commissure-posterior commissure line (TR/TE/NEX, 2300/272/1) with lipid and water suppression. Ratios of metabolite peak areas were calculated, and spectra were bilaterally evaluated. RESULTS: Diffuse or focal reductions in N-acetylaspartate were observed in the affected white matter in all three cases. These reductions seemed to be consistent with axonal damage. In addition, mild increases in choline and creatine levels were observed; these may have been due to astrocytic changes. CONCLUSION: Proton MRS imaging may be helpful in evaluating regional pathophysiologic abnormalities in PMD and in distinguishing PMD from other leukodystrophies, which exhibit different metabolic profiles.

Original languageEnglish (US)
Pages (from-to)1683-1689
Number of pages7
JournalAmerican Journal of Neuroradiology
Volume24
Issue number8
StatePublished - Sep 2003

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Clinical Neurology

Fingerprint Dive into the research topics of 'Proton MR spectroscopic imaging in Pelizaeus-Merzbacher disease'. Together they form a unique fingerprint.

  • Cite this

    Pizzini, F., Fatemi, A. S., Barker, P. B., Nagae-Poetscher, L. M., Horská, A., Zimmerman, A. W., Moser, H. W., Bibat, G., & Naidu, S. (2003). Proton MR spectroscopic imaging in Pelizaeus-Merzbacher disease. American Journal of Neuroradiology, 24(8), 1683-1689.